VORANIGO DIN 02551233
Status: Marketed
Holder: SERVIER CANADA INC
Available to quote
Health Canada record
| Active ingredient(s) | VORASIDENIB 40 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01XM04 VORASIDENIB |
|---|
| Original market date | 21-Oct-2024 |
|---|
| Current status date | 21-Oct-2024 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Servier Canada Inc — licence 100542, currently licensed, last inspection rating C (2023-05-31).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VORASIDENIB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02551225 | VORANIGO | SERVIER CANADA INC | Tablet | VORASIDENIB 10 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 33876 | 2024-08-27 | New Drug Submission (NDS) | |
Request a quote for VORANIGO
How to read a Canadian DIN record